Monocyte Activation Tests Market Future Opportunities 2026–2036
The oncology segment represents the largest portion of this market, as monoclonal antibodies are essential therapies for various cancers, including breast cancer, lung cancer, and hematological malignancies. The rising adoption of biosimilars is making monoclonal antibody